Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 13, 2009 08:15 ET | Source: Hemispherx Biopharma, Inc.

New Infectious Retrovirus Detected in Chronic Fatigue Syndrome

PHILADELPHIA, Oct. 13, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") announced today that the discovery of a novel retrovirus in CFS may now shed new light on the...
October 08, 2009 08:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx's Ampligen(R)/ Intranasal Flu Vaccine Program to be Presented At International Vaccine Workshop in Osaka

PHILADELPHIA, Oct. 8, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), announced that Dr. H. Hasegawa, Chief, Laboratory of Mucosal Vaccine Development Virus...
October 02, 2009 08:45 ET | Source: Hemispherx Biopharma, Inc.

Stanford University Presents New Data On Immuno-Potential of Hemispherx's Ampligen(R)

PHILADELPHIA, Oct. 2, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), announced that Dr. Jonathan S. Berek, Professor and Chair, Obstetrics and Gynecology,...
September 28, 2009 10:30 ET | Source: Hemispherx Biopharma, Inc.

UPDATE -- Japanese National Institute of Health to Present New Data On Hemispherx's Vaccine Enhancer

PHILADELPHIA, Sept. 28, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced data of Dr. Hasegawa, Director, the Japanese National Institute of...
September 24, 2009 09:15 ET | Source: Hemispherx Biopharma, Inc.

Japanese National Institute of Health to Present New Data on Hemispherx's Vaccine Enhancer

PHILADELPHIA, Sept. 24, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") today announced that Dr. Hasegawa, Director, at the Japanese National Institute of...
September 23, 2009 09:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Presents At the Maxim Group Annual Growth Conference

PHILADELPHIA, Sept. 23, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced that the Company will participate in the Maxim Group 3rd Annual Growth...
September 16, 2009 08:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Board of Directors Authorizes Multimillion Dollar Expansion of Its FDA Licensed Manufacturing Facilities

PHILADELPHIA, Sept. 16, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") today announced that its Board of Directors has just approved up to $4.4 Million (U.S.) for...
September 02, 2009 10:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Presents At the Rodman Healthcare Conference

PHILADELPHIA, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), today announced that the Company will participate in the Rodman & Renshaw 11th Annual...
September 02, 2009 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Cancellation of Adjourned Stockholders' Meeting

PHILADELPHIA, Sept. 2, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that insufficient votes were obtained for passage of proposal no. 3 contained in the proxy for the...
August 10, 2009 07:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. 2nd Quarter 2009 Financial Results

PHILADELPHIA, Aug. 10, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended June 30, 2009. The net loss (including non-cash...